Derek Ochiai, MD
Orthopaedic Surgery · Sterling, VANPI 1053374116
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (52.2%), royalties or licence payments and travel and lodging — rather than concentrated in one kind of arrangement. Linvatec Corporation accounts for 80.0% of it on its own, with 32 other manufacturers making up the rest. Reporting peaked in 2021 at $88,900 and has fallen 65.6% since, to $30,609 in 2025. Among orthopaedic surgery clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 347 payments — averaging $782.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Linvatec Corporation$217K
- Bioventus LLC$40K
- Joint Restoration Foundation, Inc.$6K
- Arthrex$3K
- Conmed Corporation$846
- Conformis, Inc.$797
- plus $4K from 27 others
Across 1 payment — averaging $2550.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Linvatec Corporation$3K
What the payments were for
- Royalty or licence$73,97327%
- Consulting fees$141,83852%
- Speaking & faculty fees$18,1887%
- Travel & lodging$27,59610%
- Food & beverage$10,0384%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Linvatec Corporation | 195 | $217,385 |
| Bioventus LLC | 33 | $39,804 |
| Joint Restoration Foundation, Inc. | 9 | $5,856 |
| Arthrex | 36 | $3,326 |
| Conmed Corporation | 5 | $846 |
| Conformis, Inc. | 6 | $797 |
| Supreme Orthopedic Systems, LLC | 6 | $766 |
| Pacira Pharmaceuticals Incorporated | 6 | $753 |
| Stryker | 7 | $376 |
| Smith+Nephew | 11 | $339 |
| Gemini Mountain Medical, LLC | 2 | $294 |
| Miach Orthopaedics, Inc. | 1 | $136 |
| BREG, Inc | 1 | $134 |
| Boston Scientific | 1 | $125 |
| Johnson & Johnson | 3 | $121 |
| Zimmer Biomet | 2 | $72 |
| Medtronic | 2 | $67 |
| Pacira Therapeutics, Inc. | 2 | $66 |
| Ferring Pharmaceuticals Inc. | 2 | $51 |
| Electronic Waveform Lab, Inc. | 2 | $42 |
| Vertex | 2 | $37 |
| Integra Lifesciences Corporation | 2 | $31 |
| Lifenet Health | 1 | $30 |
| Endo Pharmaceuticals Inc. | 1 | $23 |
| Convatec Inc. | 1 | $23 |
| ERMI LLC | 1 | $22 |
| Avanos Medical | 1 | $20 |
| Fidia Pharma USA Inc. | 1 | $20 |
| AstraZeneca | 1 | $15 |
| Curonix LLC | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Orthofix Medical, Inc. | 1 | $14 |
| Tactile Systems Technology Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LINVATEC HIP PRESERVATION SYSTEM$133,415
- EZSWITCH PORTAL SAVER$58,972
- Exogen Ultrasound Bone Healing System$21,488
- L360 Thigh System$15,292
- EZSTART$7,375
- PRESSFT$4,050
- EZSTART SCREW$2,976
- BioBrace 23mm$1,899
- L300 Go System$1,037
- Hip$719
- Iovera$644
- LINVATEC KNEE PRESERVATION SYSTEM$298
- LINVATEC EXTREMITIES$298
- LINVATEC SHOULDER ARTHROSCOPY$298
- Breg$268
- ALPHAVENT$160
- ICONIX$160
- HIPCHECK$160
- FLOWPORT$160
- GENERAL PAIN MANAGEMENT$125
How this compares
$271,632 in reported general payments places this provider in the 95th percentile of 473 orthopaedic surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nabumetone | 26 | $293 |
| Meloxicam | 24 | $55 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Sterling
- Randall PeytonSterling$2.9M
- Dale YoungNorth Chesterfield$10.9M
- James DowdVirginia Beach$6.1M
- Mark de BloisNorth Chesterfield$4M
- Cato LaurencinCharlottesville$3.5M
- William MihalkoCharlottesville$2M
- David MillerNorth Chesterfield$1.7M
- Keith LawhornFairfax$1.6M
- Joseph GonduskyVirginia Beach$1.2M
- Joshua HerzogNorth Chesterfield$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.